HighTower Advisors LLC lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 14.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,684 shares of the company’s stock after buying an additional 3,630 shares during the period. HighTower Advisors LLC’s holdings in Doximity were worth $1,531,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. FMR LLC lifted its stake in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after buying an additional 1,598,602 shares during the last quarter. State Street Corp lifted its stake in Doximity by 2.5% during the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock worth $160,947,000 after purchasing an additional 88,922 shares during the last quarter. Geode Capital Management LLC raised its stake in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after acquiring an additional 472,565 shares in the last quarter. Los Angeles Capital Management LLC increased its holdings in shares of Doximity by 33.7% during the fourth quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company’s stock worth $46,466,000 after buying an additional 219,448 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Doximity by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company’s stock worth $41,565,000 after buying an additional 25,523 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.
Insider Transactions at Doximity
In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 37.40% of the company’s stock.
Doximity Stock Up 5.4 %
Analyst Upgrades and Downgrades
A number of analysts have commented on DOCS shares. Raymond James reaffirmed an “outperform” rating and set a $83.00 price target (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Stephens started coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 target price on the stock. Mizuho increased their price target on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. The Goldman Sachs Group increased their price target on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Finally, Wells Fargo & Company reiterated an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Doximity currently has a consensus rating of “Moderate Buy” and a consensus target price of $64.22.
Read Our Latest Report on Doximity
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
- Five stocks we like better than Doximity
- Insider Trading – What You Need to Know
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How Technical Indicators Can Help You Find Oversold Stocks
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Evaluate a Stock Before Buying
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.